Stem Cells Market, By Product Type (Pluripotent Cells, Human Embryonic Stem Cells, Adult Stem Cells, and Others), By Source (Allogeneic, and Autologous), By Application (Development & Drug Discovery, and Regenerative Medicine), and By End User (Tissue & Cell Banks, Therapeutic Companies, Service Companies, and Reagent & Tools Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 18-Dec-2020 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-2620 Status : Published

The stem cells market is set for a rapid growth over the forecast period. In terms of revenue, the global stem cells market accounted for USD 9.8 Billion in 2019 and is expected to reach USD 17.57 Billion by 2026, growing at a CAGR of 8.7%.

Description

The stem cells market is set for a rapid growth over the forecast period. In terms of revenue, the global stem cells market accounted for USD 9.8 Billion in 2019 and is expected to reach USD 17.57 Billion by 2026, growing at a CAGR of 8.7%.

Global Stem Cells Market: Overview

The stem cell is one of the master cells for a human body; it has the capability to develop into anyone’s body more than 200 plus cell types. Stem cells are undifferentiated cells that typically belong to the same family category (lineage). They preserve the capability to divide all through the life and give augment to cells that can turn out to be extremely specialized and take the place of cells that doesn’t grow. Stem cells add to the body's ability to repair and renew its tissues and generate new cells of any tissue they belong to.

Global Stem Cells Market: Growth Factors

One of the most significant aspects which is boosting the stem cells market expansion is the limitations in conventional organ transplantations. The rising concerns with organ transplantations have boosted the demand for stem cell treatment products. Conventional or traditional organ donation method is connected with immunosuppressant risk, infection risk, and negative response. Also, the demand for organs is growing, and the physicians/doctors are completely dependent on organ donors. To rise above these issues several researchers are now discovering ways to recognize the application of stem cell therapies in different transplants. In addition, the graft rejection can be decreased with the stem cells, as these are grown utilizing the same person cells. These benefits in the transplantations of organs will result in the expansion of the global stem cells market in the future.

Global Stem Cells Market: Segmentation

The global stem cells market is classified based on sources, product type, end users, application, and geography. Based on product type, the stem cells market is categorized into induced pluripotent cells, human embryonic stem cells, adult stem cells, and others. Based on sources, the market is bifurcated into allogeneic and autologous. Based on application, the stem cells market is classified into development & drug discovery and regenerative medicine. Based on end users the market is divided into tissue & cell banks, therapeutic companies and service companies, and reagent & tools companies.

Global Stem Cells Market: Regional Analysis

Regionally, the global stem cells market is classified into North America, Asia Pacific, Europe, and the Middle East & Africa. North America is anticipated to dominate the market owing to the significant investments in this field, remarkable economic expansion, increasing instances of target chronic syndrome, and technological development. North America is followed by Europe and is estimated to grow at a significant rate in the years to come. Asia Pacific stem cells market is expected to develop at a rapid rate in the future; whereas the Middle East stem cells market is predicted to grow at a sluggish rate in the coming years.

Global Stem Cells Market: Competitive Players

Some of the major key players in the global stem cells market are Osiris Therapeutics Inc., STEMCELL Technologies Inc., BIOTIME, Inc., Celgene Corporation, Human Longevity Inc., Cynata, Cytori Therapeutics, Promethera Biosciences, and Advanced Cell Technology Inc., among others.

Global Stem Cells Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodulogy
    • 2.1.Research Methodulogy
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Stem Cells Market, 2016 – 2026 (USD Million)
    • 3.2.Global Stem Cells Market: Snapshot
  • Chapter 4.Stem Cells Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Stem Cells
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technulogy Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Stem Cells Market Attractiveness, By Product Type
    • 5.2.Global Stem Cells Market Attractiveness, By Source
    • 5.3.Global Stem Cells Market Attractiveness, By Application
    • 5.4.Global Stem Cells Market Attractiveness, By End User
    • 5.5.Global Stem Cells Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Stem Cells Market: Company Market Share, 2019
    • 6.2.Strategic Developments
  • Chapter 7.Stem Cells Market – Product Type Segment Analysis
    • 7.1.Global Stem Cells Market Overview: by Product Type
      • 7.1.1.Global Stem Cells Market Revenue Share, by Product Type, 2019 & 2026
    • 7.2.Global Stem Cells Market Analysis/Overview – By Product Type
      • 7.2.1.Pluripotent Cells – Overview/Analysis
      • 7.2.2.Human Embryonic Stem Cells – Overview/Analysis
      • 7.2.3.Adult Stem Cells – Overview/Analysis
      • 7.2.4.Others – Overview/Analysis
    • 7.3.Pluripotent Cells
      • 7.3.1.Global Stem Cells Market for Pluripotent Cells, Revenue (USD Million) 2016 - 2026
    • 7.4.Human Embryonic Stem Cells
      • 7.4.1.Global Stem Cells Market for Human Embryonic Stem Cells, Revenue (USD Million) 2016 - 2026
    • 7.5.Adult Stem Cells
      • 7.5.1.Global Stem Cells Market for Adult Stem Cells, Revenue (USD Million) 2016 - 2026
    • 7.6.Others
      • 7.6.1.Global Stem Cells Market for Others, Revenue (USD Million) 2016 - 2026
  • Chapter 8.Stem Cells Market – Source Segment Analysis
    • 8.1.Global Stem Cells Market Overview: by Source
      • 8.1.1.Global Stem Cells Market Revenue Share, by Source, 2019 & 2026
    • 8.2.Global Stem Cells Market Analysis/Overview – By Source
      • 8.2.1.Allogeneic – Overview/Analysis
      • 8.2.2.Autulogous – Overview/Analysis
    • 8.3.Allogeneic
      • 8.3.1.Global Stem Cells Market for Allogeneic, Revenue (USD Million) 2016 - 2026
    • 8.4.Autulogous
      • 8.4.1.Global Stem Cells Market for Autulogous, Revenue (USD Million) 2016 - 2026
  • Chapter 9.Stem Cells Market – Application Segment Analysis
    • 9.1.Global Stem Cells Market Overview: by Application
      • 9.1.1.Global Stem Cells Market Revenue Share, by Application, 2019 & 2026
    • 9.2.Global Stem Cells Market Analysis/Overview – By Application
      • 9.2.1.Development & Drug Discovery – Overview/Analysis
      • 9.2.2.Regenerative Medicine – Overview/Analysis
    • 9.3.Development & Drug Discovery
      • 9.3.1.Global Stem Cells Market for Development & Drug Discovery, Revenue (USD Million) 2016 - 2026
    • 9.4.Regenerative Medicine
      • 9.4.1.Global Stem Cells Market for Regenerative Medicine, Revenue (USD Million) 2016 - 2026
  • Chapter 10.Stem Cells Market – End User Segment Analysis
    • 10.1.Global Stem Cells Market Overview: by End User
      • 10.1.1.Global Stem Cells Market Revenue Share, by End User, 2019 & 2026
    • 10.2.Global Stem Cells Market Analysis/Overview – By End User
      • 10.2.1.Tissue & Cell Banks – Overview/Analysis
      • 10.2.2.Therapeutic Companies – Overview/Analysis
      • 10.2.3.Service Companies – Overview/Analysis
      • 10.2.4.Reagent & Touls Companies – Overview/Analysis
    • 10.3.Tissue & Cell Banks
      • 10.3.1.Global Stem Cells Market for Tissue & Cell Banks, Revenue (USD Million) 2016 - 2026
    • 10.4.Therapeutic Companies
      • 10.4.1.Global Stem Cells Market for Therapeutic Companies, Revenue (USD Million) 2016 - 2026
    • 10.5.Service Companies
      • 10.5.1.Global Stem Cells Market for Service Companies, Revenue (USD Million) 2016 - 2026
    • 10.6.Reagent & Touls Companies
      • 10.6.1.Global Stem Cells Market for Reagent & Touls Companies, Revenue (USD Million) 2016 - 2026
  • Chapter 11.Stem Cells Market – Regional Analysis
    • 11.1.Global Stem Cells Market: Regional Overview
      • 11.1.1.Global Stem Cells Market Revenue Share, by Region, 2019 & 2026
      • 11.1.2.Global Stem Cells Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 11.2.North America
      • 11.2.1.North America Stem Cells Market Revenue, 2016 - 2026 (USD Million)
      • 11.2.2.North America Stem Cells Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.2.3.North America Stem Cells Market Revenue, by Product Type, 2016 – 2026
      • 11.2.4.North America Stem Cells Market Revenue, by Source, 2016 – 2026
      • 11.2.5.North America Stem Cells Market Revenue, by Application, 2016 – 2026
      • 11.2.6.North America Stem Cells Market Revenue, by End User, 2016 – 2026
      • 11.2.7. U.S.
      • 11.2.8.Canada
      • 11.2.9.Mexico
    • 11.3.Europe
      • 11.3.1.Europe Stem Cells Market Revenue, 2016 - 2026 (USD Million)
      • 11.3.2.Europe Stem Cells Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.3.3.Europe Stem Cells Market Revenue, by Product Type, 2016 – 2026
      • 11.3.4.Europe Stem Cells Market Revenue, by Source, 2016 – 2026
      • 11.3.5.Europe Stem Cells Market Revenue, by Application, 2016 – 2026
      • 11.3.6.Europe Stem Cells Market Revenue, by End User, 2016 – 2026
      • 11.3.7.Germany
      • 11.3.8.France
      • 11.3.9. U.K.
      • 11.3.10.Italy
      • 11.3.11.Spain
      • 11.3.12.Rest of Europe
    • 11.4.Asia Pacific
      • 11.4.1.Asia Pacific Stem Cells Market Revenue, 2016 - 2026 (USD Million)
      • 11.4.2.Asia Pacific Stem Cells Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.4.3.Asia Pacific Stem Cells Market Revenue, by Product Type, 2016 – 2026
      • 11.4.4.Asia Pacific Stem Cells Market Revenue, by Source, 2016 – 2026
      • 11.4.5.Asia Pacific Stem Cells Market Revenue, by Application, 2016 – 2026
      • 11.4.6.Asia Pacific Stem Cells Market Revenue, by End User, 2016 – 2026
      • 11.4.7.China
      • 11.4.8.Japan
      • 11.4.9.India
      • 11.4.10.South Korea
      • 11.4.11.South-East Asia
      • 11.4.12.Rest of Asia Pacific
    • 11.5.Latin America
      • 11.5.1.Latin America Stem Cells Market Revenue, 2016 - 2026 (USD Million)
      • 11.5.2.Latin America Stem Cells Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.5.3.Latin America Stem Cells Market Revenue, by Product Type, 2016 – 2026
      • 11.5.4.Latin America Stem Cells Market Revenue, by Source, 2016 – 2026
      • 11.5.5.Latin America Stem Cells Market Revenue, by Application, 2016 – 2026
      • 11.5.6.Latin America Stem Cells Market Revenue, by End User, 2016 – 2026
      • 11.5.7.Brazil
      • 11.5.8.Mexico
      • 11.5.9.Rest of Latin America
    • 11.6.The Middle-East and Africa
      • 11.6.1.The Middle-East and Africa Stem Cells Market Revenue, 2016 - 2026 (USD Million)
      • 11.6.2.The Middle-East and Africa Stem Cells Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.6.3.The Middle-East and Africa Stem Cells Market Revenue, by Product Type, 2016 – 2026
      • 11.6.4.The Middle-East and Africa Stem Cells Market Revenue, by Source, 2016 – 2026
      • 11.6.5.The Middle-East and Africa Stem Cells Market Revenue, by Application, 2016 – 2026
      • 11.6.6.The Middle-East and Africa Stem Cells Market Revenue, by End User, 2016 – 2026
      • 11.6.7.GCC Countries
      • 11.6.8.South Africa
      • 11.6.9.Rest of Middle-East Africa
  • Chapter 12.Company Profiles
    • 12.1.Osiris Therapeutics Inc.
      • 12.1.1.Company Overview
      • 12.1.2.Financial Overview
      • 12.1.3.Product Portfulio
      • 12.1.4.Business Strategy
      • 12.1.5.Recent Developments
    • 12.2.STEMCELL Technulogies Inc.
    • 12.3.BIOTIME Inc.
    • 12.4.Celgene Corporation
    • 12.5.Human Longevity Inc.
    • 12.6.Cynata
    • 12.7.Cytori Therapeutics
    • 12.8.Promethera Biosciences
    • 12.9.Advanced Cell Technulogy Inc.

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com